MedPath

BIS Monitoring in Relation to Muscle Relaxant Administration

Completed
Conditions
Anesthesia
Cardiovascular Surgery
Bispectral Index
Interventions
Device: Bispectral Index (BIS) monitoring system
Registration Number
NCT05440058
Lead Sponsor
Mayo Clinic
Brief Summary

The purpose of this study is to determine the overall optimal timing of when the Bispectral Index (BIS) monitor should be started: before or after the muscle relaxant is given.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
22
Inclusion Criteria
  • Undergoing elective cardiac surgery
  • Muscle relaxation administration by rocuronium
Read More
Exclusion Criteria
  • Patient refusal
  • Pediatric patients
  • Emergency procedure
  • Patients with known or suspected carotid or cerebrovascular disease
  • Patients with prior stroke
  • Skin condition or anatomy preventing proper sensor placement
  • Patients who receive ketamine during the study timeframe
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BIS MonitoringBispectral Index (BIS) monitoring systemSubjects will have BIS sensors applied to forehead
Primary Outcome Measures
NameTimeMethod
BIS Values25-minute period in the operating room

Parameters measured from both left and right BIS sensors. BIS monitor algorithm to process EEG information second by second and outputs a number (0-100) that corresponds with a patient's level of consciousness. A level of 0 indicates no EEG activity; a level of 100 indicates awake EEG activity.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath